Sugi Predict

Sugi Predict / Compounds / SCHEMBL5228130

SCHEMBL5228130

SCHEMBL5228130

Cn1nc(C2CCCCC2)c2c(=O)[nH]c(-c3ccc(S(=O)(=O)N4CCCNCC4)cc3)nc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE7A Q13946 3/20 0.48
▸ CA12 O43570 3/20 0.45
▸ ABL1 P00519 3/20 0.45
▸ CA2 P00918 2/20 0.45
▸ ADORA3 P0DMS8 2/20 0.40
▸ ADORA2B P29275 2/20 0.40
▸ PDE5A O76074 4/20 0.40
▸ PDE1A P54750 2/20 0.40
▸ PDE1B Q01064 2/20 0.40
▸ PDE1C Q14123 2/20 0.40
▸ CCNE1 P24864 1/20 0.38
▸ CDK2 P24941 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ PDE7B Q9NP56 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ APOBEC3A P31941 1/20 0.37
▸ APOBEC3G Q9HC16 1/20 0.37
▸ IKBKB O14920 2/20 0.37
▸ MAPK8 P45983 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5230592 0.89 PDE7A (0.49) PDE7AADORA3ADORA2BPDE5APDE1A
SCHEMBL5235905 0.88 PDE7A (0.49) PDE7AADORA3ADORA2BPDE5APDE1A
SCHEMBL1955952 0.86 CA12 (0.41) CA12ABL1CA2ADORA3ADORA2B
SCHEMBL5235269 0.86 PDE7A (0.46) PDE7AADORA3ADORA2BPDE5APDE1A
SCHEMBL5236243 0.86 PDE7A (0.65) PDE7ACA12ABL1PDE5APDE1A
SCHEMBL5230233 0.83 PDE7A (0.55) PDE7AADORA3ADORA2BPDE5APDE1A
SCHEMBL5233950 0.83 PDE7A (0.62) PDE7APDE5APDE1APDE1BPDE1C
SCHEMBL5233086 0.78 PDE7A (0.58) PDE7AADORA3ADORA2BPDE5A
SCHEMBL5234599 0.78 PDE7A (0.69) PDE7AADORA2BPDE5APDE7B
SCHEMBL5237929 0.78 PDE7A (0.60) PDE7AADORA3ADORA2BPDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1454897-B1 PYRAZOLOPYRIMIDINONE DERIVATIVES HAVING PDE7-INHIBITORY ACTIVITY ASUBIO PHARMA CO LTD (JP) 2007-10-10 — — EP disclosed
EP-1454897-B1 PYRAZOLOPYRIMIDINONE DERIVATIVES HAVING PDE7-INHIBITORY ACTIVITY ASUBIO PHARMA CO LTD (JP) 2007-10-10 — — EP disclosed
US-7268128-B2 1,3,5-trisubstituted-5-phenyl and 5-pyridyl pyrazolopyrimidinone derivatives having PDE7 inhibiting action AUSBIO PHARMA CO., LTD. (JP) 2007-09-11 — — US disclosed
US-7268128-B2 1,3,5-trisubstituted-5-phenyl and 5-pyridyl pyrazolopyrimidinone derivatives having PDE7 inhibiting action AUSBIO PHARMA CO., LTD. (JP) 2007-09-11 — — US disclosed
US-7268128-B2 1,3,5-trisubstituted-5-phenyl and 5-pyridyl pyrazolopyrimidinone derivatives having PDE7 inhibiting action AUSBIO PHARMA CO., LTD. (JP) 2007-09-11 — — US disclosed
US-20050148604-A1 Pyrazolopyrimidinone derivatives having PDE7 inhibiting action OMEROS CORPORATION 2005-07-07 — — US disclosed
EP-1454897-A1 PYRAZOLOPYRIMIDINONE DERIVATIVES HAVING PDE7−INHIBITORY ACTIVITY Daiichi Suntory Pharma Co., Ltd. (JP) 2004-09-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050148604-A1 Pyrazolopyrimidinone derivatives having PDE7 inhibiting action PDE7B, PDE3B, PDE3A PDE7A 4/4885CA12 4687/4885ABL1 2309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.